Travel-related vaccines (Q34218609)

31 July 2017

1 reference

title

Travel-related vaccines (English)

1 reference

31 July 2017

Wilson ME

1

1 reference

31 July 2017

1 March 2001

1 reference

Infectious Disease Clinics of North America

31 July 2017

1 reference

31 July 2017

15

1 reference

31 July 2017

1

1 reference

31 July 2017

231-251

1 reference

Vaccine-associated measles pneumonitis in an adult with AIDS.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Clinical experience with an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

A global review of rabies vaccines for human use.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Circumstances and management of 72 animal bites among long-term residents in the tropics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Tuberculosis Risk and Prevention in Travelers-What about BCG?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immunizations for international travel

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Tropical infectious diseases in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Hepatitis A vaccine and travel departure

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Pretravel advice neglects rabies risk for travelers to tropical countries

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Vaccination of travelers against hepatitis A and B.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immune response of the elderly to rabies vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Imported yellow fever in a United States citizen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Facing up to re-emergence of urban yellow fever

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Yellow fever vaccination and pregnancy: a four-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Adverse reactions to Japanese encephalitis vaccine in travellers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Neurological complications to vaccination against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Allergic mucocutaneous reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Neurological complications and Japanese encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Interruption of an outbreak of hepatitis A in two villages by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Hepatitis B vaccine responsiveness in Connecticut public safety personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Responses to measles immunization in children infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Chickenpox--a disease predominantly affecting adults in rural West Bengal, India

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immunogenicity of an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

The first combined vaccine against hepatitis A and B: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Immunogenicity of two recombinant hepatitis B vaccines in older individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Chloroquine does not adversely affect the antibody response to yellow fever vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Congenital yellow fever virus infection after immunization in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Urbanisation of yellow fever in Santa Cruz, Bolivia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Simultaneous active and passive immunization against hepatitis A studied in a population of travellers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Six years' follow-up after hepatitis A vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Critical Evaluation of Vaccines for Travelers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Applying experiences from trials of bacille Calmette-Guérin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Infections in HIV-infected travelers: risks and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

Progressive immunodeficiency due to infection with human immunodeficiency virus does not lead to waning immunity to measles in a cohort of homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970277-4

7 January 2021

10.1016/S0891-5520(05)70277-4

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11301818